tirzepatide 5ml vial Mounjaro® 5mg – Injection – FILLERFY Mounjaro (Tirzepatide) Injection 7.5 mg/0.5

Purpose of Review Moderate hypertriglyceridemia is exceedingly common in diabetes, and there is growing evidence that it contributes to residual cardiovascular risk in statin-optimized patients

vitamin D intake ~20% of recommendations Lean mass risk: protein + calcium insufficiency may contribute, alongside other drivers B-vitamins: thiamine and cobalamin deficits appear to increase over time Clinical takeaway (my approach): GLP-1s dont cause malnutrition in everyone but they can unmask risk in the wrong context (older adults, low-protein diets, restrictive eating patterns, prolonged nausea/vomiting, rapid weight loss, post-bariatric patients)

Additionally, weight loss medications were discussed as potential treatments for patients given the link between the disease and obesity

Eli Lilly has filed a motion calling for a federal judge to put in place specific requirements for establishing a gastroparesis diagnosis in stomach paralysis lawsuits filed against the makers of Mounjaro, Ozempic and other GLP-1 medications.

Gala GLP-1 Reviews & Complaints Gala GLP-1 label details include active compound name, dosing cadence, prescribing clinician, and dispensing pharmacy contact on the shipment

Do not take if you have a condition that causes iron accumulation